Tm. Ko et Xm. Xu, MOLECULAR STUDY AND PRENATAL-DIAGNOSIS OF ALPHA-THALASSEMIA AND BETA-THALASSEMIA IN CHINESE, Journal of the Formosan Medical Association, 97(1), 1998, pp. 5-15
Thalassemia is one of the most common single gene diseases worldwide.
Populations in southern China and Taiwan have high prevalence rates of
ex-and beta-thalassemias. This review summarizes the current status o
f molecular studies, carrier screening, and prenatal diagnosis of thal
assemia in Chinese. There are three genotypes of alpha-thalassemia 1 a
nd at least six of alpha-thalassemia 2 in Chinese. For alpha-thalassem
ia 1, the South-East Asian deletion is the most common, followed by th
e Thai then Philippine deletions. For alpha-thalassemia 2, the rightwa
rd deletion is the most common, followed by the leftward deletion, and
tile nondeletional defects Hb Constant Spring and Hb Quong Sze. Twent
y-eight different beta-thalassemia mutations have been reported. Four
mutations, IVS-II-654 (C-->T), codons 41/42 frameshift (-TCTT), and no
nsense codons 17 (A-->T) and -28 (A-->G), account for more than 90% of
mutant alleles. For detection of alpha-thalassemia, polymerase chain
reaction-related techniques are mainly used. Southern blot hybridizati
on is still useful, especially for prenatal diagnosis. For detection o
f beta-thalassemia mutations,ns, analysis of amplification-created res
triction sites and reverse dot blot hybridization have been extensivel
y used. In Taiwan, a national screening program incorporating hematolo
gical and molecular biological methods for thalassemia detection in pr
egnant women has been in progress for 5 years. Prenatal diagnosis has
been performed in more than 1,800 pregnancies, including 1,500 cases a
t risk for homozygous alpha-thalassemia 1 and 300 for beta-thalassemia
major, resulting in early prenatal diagnosis and termination of pregn
ancies affected with homozygous alpha-thalassemia 1 and an approximate
ly!; 70% decrease in the number of newborns affected with beta-thalass
emia major. In mainland China, only one large-scale screening program
is in place. Characterization of undefined alleles, a higher awareness
of the disease among physicians and the general public, and improveme
nt of the service;ice network will be important for early prenatal dia
gnosis and prevention of the disease in the future.